ヘルスケアAI
2026年6月18日
今日の要点
Merck, Protillion Launch AI Drug Discovery Collaboration with Up-to-$510M in Milestone Payments. Pramaana Labs raises $27M seed round from Khosla Ventures to bring formal verification to AI. New research shows how AMIE, our medical AI, could help manage health conditions. Merck and Protillion ink AI drug discovery deal worth up to $510M. Protillion and Merck & Co sign AI drug discovery pact. General-purpose LLMs outperform specialized clinical AI tools. Pfizer signs licence agreement with Chai for AI drug discovery. AI Agent Failure Detection and Root Cause Analysis with Strands Evals. The researchers who built AI-generated DNA just raised $50 million to reinvent biology. General-purpose large language models outperform specialized clinical AI
主要ニュース
- 1
Merck, Protillion Launch AI Drug Discovery Collaboration with Up-to-$510M in Milestone Payments
Merck, Protillion Launch AI Drug Discovery Collaboration with Up-to-$510M in Milestone Payments Genetic Engineering and Biotechnology News
- 2
Pramaana Labs raises $27M seed round from Khosla Ventures to bring formal verification to AI
Pramaana will focus on highly sensitive verticals like law, drug discovery, and tax preparation — where errors can be costly and reliability is at a premium.
- 3
New research shows how AMIE, our medical AI, could help manage health conditions
Research in “Nature” shows our conversational AI system matches primary care physicians in complex disease management.
- 4
Merck and Protillion ink AI drug discovery deal worth up to $510M
Merck and Protillion ink AI drug discovery deal worth up to $510M Seeking Alpha
- 5
Protillion and Merck & Co sign AI drug discovery pact
Protillion and Merck & Co sign AI drug discovery pact The Pharma Letter
今後の注目点
Follow the sources below for updates.
情報ソース
- Merck, Protillion Launch AI Drug Discovery Collaboration with Up-to-$510M in Milestone Payments
- Pramaana Labs raises $27M seed round from Khosla Ventures to bring formal verification to AI
- New research shows how AMIE, our medical AI, could help manage health conditions
- Merck and Protillion ink AI drug discovery deal worth up to $510M
- Protillion and Merck & Co sign AI drug discovery pact
- General-purpose LLMs outperform specialized clinical AI tools
- Pfizer signs licence agreement with Chai for AI drug discovery
- AI Agent Failure Detection and Root Cause Analysis with Strands Evals
- The researchers who built AI-generated DNA just raised $50 million to reinvent biology
- General-purpose large language models outperform specialized clinical AI
このニュースを友達にシェア
気になりそうな人に、今日のまとめをそのまま送れます。
AITodayで毎日のAIニュースを無料で受け取る
200以上のAIソースを毎朝1分で。Email / LINE / Slack 配信。
無料で登録する